New Delhi: Drug-makers Sun Pharma and Ranbaxy on Monday got fair trade watchdog CCI's approval for their long-pending USD 4-billion merger, but with a condition that they will have to modify the deal by divesting
Mumbai: The Competition Commission is likely to take the final decision in the USD 4 billion Sun Pharma-Ranbaxy deal by the end of this month, fair trade watchdog's chairman Ashok Chawla has said.This big ticket
Top News
Latest News
